Bassel Nazha

Also affiliated with Piedmont Cancer Institute

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 21 papers. Top paper: “Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II study”.

Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II study

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001302

N/A

2.2DataRank · unranked

66 citations

Kristin Higgins, Zhengjia Chen, Gabriel Sica, Conor Steuer, Chao Zhang +12 more

Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad155

N/A

0.609DataRank · unranked

57 citations

Amin H. Nassar, Gregory R. Pond, Tony Zhuang, Viraj A. Master, Bassel Nazha +50 more

Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002851

N/A

0.515DataRank · unranked

30 citations

Yuan Liu, Julie M. Shabto, Dylan J. Martini, Deepak Ravindranathan, Emilie Elise Hitron +13 more

PD‐L1 and nectin‐4 expression and genomic characterization of bladder cancer with divergent differentiation

Cancer(2024)10.1002/cncr.35465

N/A

0.422DataRank · unranked

6 citations

Katherine Case, Derrik Gratz, Kathryn L. Pellegrini, Elizabeth Beagle, Thomas M. Schneider +12 more

Clinical Outcomes and Racial Disparities in Metastatic Hormone-Sensitive Prostate Cancer in the Era of Novel Treatment Options

The Oncologist(2021)10.1002/onco.13848

N/A

0.373DataRank · unranked

11 citations

Jacqueline T. Brown, Limeng Wan, Yuan Liu, Greta Russler, Lauren Yantorni +8 more

Phase II trial of opaganib in patients with metastatic castration-resistant prostate cancer progressing on abiraterone or enzalutamide (NCT04207255).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.tps191

N/A

0.242DataRank · unranked

3 citations

Charles D. Smith, Terry F. Plasse, Besim Öğretmen, Shikhar Mehrotra, Theodore Stewart Gourdin +6 more

Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience

Journal of Immunotherapy and Precision Oncology(2022)10.36401/jipo-22-2

N/A

0.104DataRank · unranked

1 citations

T. Anders Olsen, Subir Goyal, Yuan Liu, Sean T. Evans, Emilie Elise Hitron +12 more

Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

The Oncologist(2022)10.1093/oncolo/oyac236

N/A

0DataRank · unranked

13 citations

Deepak Ravindranathan, Yuan Liu, Dylan J. Martini, Jacqueline T. Brown, Bassel Nazha +8 more

Concurrent Androgen Deprivation Therapy for Prostate Cancer Improves Survival for Synchronous or Metachronous Non-Small Cell Lung Cancer: A SEER–Medicare Database Analysis

Cancers(2022)10.3390/cancers14133206

N/A

0DataRank · unranked

7 citations

Chao Zhang, Zhengjia Chen, Camille Ragin, Taofeek K. Owonikoko, Bassel Nazha

478 Real-world outcomes in patients with penile squamous cell carcinoma (pSCC) receiving immune checkpoint inhibitors (ICI)

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0478

N/A

0DataRank · unranked

3 citations

Subir Goyal, Jacqueline Brown, Bradley Curtis Carthon, Ömer Küçük, Greta R. McClintock +5 more

Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors

The Oncologist(2023)10.1093/oncolo/oyad154

N/A

0DataRank · unranked

12 citations

Julie M. Shabto, Subir Goyal, Yuan Liu, Dylan J. Martini, Bassel Nazha +13 more

Association of baseline inflammatory biomarkers with outcomes in penile squamous cell carcinoma (pSCC) treated with immune checkpoint inhibitors (ICI).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.11

N/A

0DataRank · unranked

2 citations

Subir Goyal, Jacqueline T. Brown, Bradley Curtis Carthon, Ömer Küçük, Greta Russler McClintock +5 more

Trop-2 and Ephrin B2 expression in urothelial carcinoma with divergent differentiation and aggressive urothelial carcinoma subtypes

American Journal of Clinical Pathology(2024)10.1093/ajcp/aqae161

N/A

0DataRank · unranked

5 citations

Dylan J. Martini, Melad Dababneh, Samuel Bidot, Bassel Nazha, Jacqueline T. Brown +7 more

Real-World Outcomes in Patients with Advanced Penile Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Single Institution Experience

Journal of Immunotherapy and Precision Oncology(2024)10.36401/jipo-24-19

N/A

0DataRank · unranked

4 citations

Subir Goyal, Katherine Case, T. Anders Olsen, Shalini Vemuru, Ahmet Yıldırım +8 more

Phase 2 Study of Perioperative Lenvatinib with Pembrolizumab in Patients with Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma 3215

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.1039

N/A

0DataRank · unranked

0 citations

BaoHan T. Vo, Mehmet Asım Bilen, Yuan Liu, Amir H. Davarpanah, Bassel Nazha +16 more

Efficacy and safety of immune checkpoint blockade in self‐identified Black patients with advanced non–small cell lung cancer

Cancer(2020)10.1002/cncr.33141

N/A

0DataRank · unranked

24 citations

Subir Goyal, Zhengjia Chen, Anne Engelhart, Jennifer W. Carlisle, Tyler Beardslee +7 more

Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

The Oncologist(2021)10.1002/onco.13868

N/A

0DataRank · unranked

43 citations

Subir Goyal, Yuan Liu, Sean T. Evans, T. Anders Olsen, Katherine Case +14 more

Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors

The Oncologist(2021)10.1002/onco.13922

N/A

0DataRank · unranked

32 citations

Julie M. Shabto, Subir Goyal, Yuan Liu, T. Anders Olsen, Sean T. Evans +17 more

Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade

Frontiers in Oncology(2021)10.3389/fonc.2021.701345

N/A

0DataRank · unranked

9 citations

Dylan J. Martini, Subir Goyal, Yuan Liu, Sean T. Evans, Benjamin Magod +12 more

Association of basophil to lymphocyte ratio (BLR) with clinical outcomes in metastatic hormone sensitive prostate cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e17049

N/A

0DataRank · unranked

0 citations

Limeng Wan, Yuan Liu, Jacqueline T. Brown, Greta Russler, Lauren Yantorni +7 more

Baseline basophil and basophil-to-lymphocyte status is associated with clinical outcomes in metastatic hormone sensitive prostate cancer

Urologic Oncology Seminars and Original Investigations(2022)10.1016/j.urolonc.2022.03.016

N/A

0DataRank · unranked

25 citations

Katherine E. Smith, Limeng Wan, Jacqueline T. Brown, Greta Russler, Lauren Yantorni +9 more